Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
661-01-010 ISMRM Abstract

Voxelwise T2-Corrected Multi-TE ASL for Perfusion and Permeability Difference in Gliomas and Meningiomas

Primary: Neuro - Tumors
Secondary: Analysis Methods - Data Processing
661-01-010 · Advances in ASL · Thursday, 14 May, 8:30 AM–9:25 AM · Digital Posters Row B
Keywords: Permeability Brain Tumor Imaging Perfusion MRI Perfusion quantification Perfsuion
Accepted
Ayse Irem Cetin 1, Gülce Turhan1, Beatriz E Padrela2,3, Amnah Mahroo4,5, Arda Canbaş1, Simon Konstandin4, Daniel Christopher Hoinkiss4, Nora-Josefin Breutigam4, Vera Keil2,3, Ayca Ersen Danyeli6,7, Koray Özduman6,8, Klaus Eickel4,9, Henk J Mutsaerts2,3,10, Matthias Günther4,11,12, Jan Petr10,13, Alp Dinçer6,14, Esin Ozturk Isik1,6
1Institute of Biomedical Engineering, Bogazici University, Istanbul, Turkey
2Brain Imaging, Amsterdam Neuroscience, Amsterdam, Netherlands
3Radiology and Nuclear Medicine, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands
4Fraunhofer Institute for Digital Medicine MEVIS, Bremen, Germany
5University Health Network, Toronto, Canada
6Brain Tumor Research Group, Acibadem University, Istanbul, Turkey
7Department of Pathology, Acibadem University, Istanbul, Turkey
8Department of Neurosurgery, Acibadem University, Istanbul, Turkey
9Bremerhaven University of Applied Sciences, Bremerhaven, Germany
10Amsterdam University Medical Center, University of Amsterdam, Amsterdam, Netherlands
11mediri GmbH, Heidelberg, Germany
12University of Bremen, Bremen, Germany
13Helmholtz-Zentrum Dresden Rossendorf, Germany
14Department of Radiology, Acibadem University, Istanbul, Turkey
Presenting Author: Ayse Irem Cetin

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Maggio I, Franceschi E, Tosoni A, et al. Meningioma: Not always a benign tumor. A review of advances in the treatment of meningiomas. CNS Oncol. 2021;10(2). doi:10.2217/cns-2021-0003 [doi]
2. Śledzińska P, Bebyn MG, Furtak J, Kowalewski J, Lewandowska MA. Prognostic and predictive biomarkers in gliomas. Int J Mol Sci.MDPI. 2021;22(19):10373. doi:10.3390/ijms221910373 [doi]
3. Mahroo A, Konstandin S, Günther M. Blood–Brain Barrier Permeability to Water Measured Using Multiple Echo Time Arterial Spin Labeling MRI in the Aging Human Brain. J Magn Reson Imaging. 2024;59(4):1269-1282. doi:10.1002/jmri.28874 [doi]
4. Mahroo A, Buck MA, Huber J, et al. Robust Multi-TE ASL-Based Blood–Brain Barrier Integrity Measurements. Front Neurosci. 2021;15:719676. doi:10.3389/fnins.2021.719676 [doi]
5. Hoffmann G, Preibisch C, Günther M, et al. Noninvasive blood–brain barrier integrity mapping in patients with high‐grade glioma and metastasis by multi–echo time–encoded arterial spin labeling. Magn Reson Med. 2025;93(5):2086-2098. doi:10.1002/mrm.30415 [doi]
6. Gu W, Fang S, Hou X, Ma D, Li S. Exploring diagnostic performance of T2 mapping in diffuse glioma grading. Quant Imaging Med Surg. 2021;11(7):2943-2954. doi:10.21037/qims-20-916 [doi]
7. Oh J, Cha S, Aiken AH, et al. Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema. J Magn Reson Imaging. 2005;21(6):701-708. doi:10.1002/jmri.20335 [doi]
8. Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231-1251. doi:10.1093/neuonc/noab106 [doi]
9. Konstandin S, Günther M, Hoinkiss DC. gammaSTAR: A framework for the development of dynamic, real-time capable MR sequences. Magn Reson Med. 2025;94(4):1485-1499. doi:10:1002/mrm.30573
10. Fedorov A, Beichel R, Kalpathy-Cramer J, et al. 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging. 2012;30(9);1323-1341. doi:10.1016/j.mri.2012.05.001 [doi]
11. Mutsaerts HJMM, Petr J, Groot P, et al. ExploreASL: An image processing pipeline for multi-center ASL perfusion MRI studies. Neuroimage. 2020;219:117031. doi:10.1016/j.neuroimage.2020.117031 [doi]
12. Keil VC, Pintea B, Gielen GH, et al. Meningioma assessment: Kinetic parameters in dynamic contrast-enhanced MRI appear independent from microvascular anatomy and VEGF expression. J of Neuroradiology. 2018;45(4):242-248. doi:10.1016/j.neurad.2018.01.050 [doi]
13. Noguchi T, Yoshiura T, Hiwatashi A, et al. Perfusion imaging of brain tumors using arterial spin-labeling: Correlation with histopathologic vascular density. AJNR Am J Neuroradiol. 2008;29(4):688-693. doi:10.3174/ajnr.A0903 [doi]
14. Hakyemez B, Erdogan C, Bolca N, Yildirim N, Gokalp G, Parlak M. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging. 2006;24(4):817-824. doi:10.1002/jmri.20707 [doi]
15. Hussain NS, Moisi MD, Keogh B, et al. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas. J Neurosurg. 2017;126(4):1220-1226. doi:10.3171/2016.3.JNS14243 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/661-01-010